Cargando…

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study

BACKGROUND: Erlotinib is a drug used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Severe hepatotoxicity was observed in 4% to 31% of patients receiving erlotinib treatment prompting delay or termination of treatment. Only a few factors related to hepatotoxicity of e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min Kyoung, Yee, Jeong, Cho, Yoon Sook, Jang, Hong Won, Han, Ji Min, Gwak, Hye Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191908/ https://www.ncbi.nlm.nih.gov/pubmed/30326853 http://dx.doi.org/10.1186/s12885-018-4891-7

Ejemplares similares

Factors Influencing Imatinib-Induced Hepatotoxicity
por: Han, Ji Min, et al.
Publicado: (2020)

Machine Learning Approaches to Predict Hepatotoxicity Risk in Patients Receiving Nilotinib
por: Kim, Jung-Sun, et al.
Publicado: (2021)

A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors
por: Han, Ji Min, et al.
Publicado: (2022)

Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013)

Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance
por: Lee, Sooyeun, et al.
Publicado: (2017)

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases
por: Yano, Yukihiro, et al.
Publicado: (2012)

Association between ABCA1 Gene Polymorphisms and Plasma Lipid Concentration: A Systematic Review and Meta-Analysis
por: Shim, Sun-Young, et al.
Publicado: (2021)

Association between Statin Use and Sensorineural Hearing Loss in Type 2 Diabetic Patients: A Hospital-Based Study
por: Han, Hye-Won, et al.
Publicado: (2021)

Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity
por: Yamanaka, Yumie, et al.
Publicado: (2017)

The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
por: Yee, Jeong, et al.
Publicado: (2020)

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
por: Cho, Kyoung Min, et al.
Publicado: (2015)

Liver transplantation in an adult patient with hepatocellular carcinoma following liver cirrhosis as a complication of the Fontan procedure -A case report-
por: Cho, Min-kyung, et al.
Publicado: (2020)

Sarcomatoid carcinoma of the pancreas — multimodality imaging findings with serial imaging follow-up: A case report and review of literature
por: Lim, Hyun Jae, et al.
Publicado: (2021)

Combined Use of Febuxostat and Colchicine Does Not Increase Acute Hepatotoxicity in Patients with Gout: A Retrospective Study
por: Oh, Yoon-Jeong, et al.
Publicado: (2020)

Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
por: Nagano, Tatsuya, et al.
Publicado: (2011)

A Case of Cicatricial Alopecia Associated with Erlotinib
por: Yang, Bo Hee, et al.
Publicado: (2011)

Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban
por: Han, Ji Min, et al.
Publicado: (2023)

Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
por: Lee, Yeonhong, et al.
Publicado: (2022)

Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis
por: Yoon, Ha Young, et al.
Publicado: (2020)

Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity
por: Song, Im-Sook, et al.
Publicado: (2021)

Clinical manifestations and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis
por: Yee, Jeong, et al.
Publicado: (2020)

ABCA1 69C>T Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Systematic Review and Updated Meta-Analysis
por: Yoon, Ha Young, et al.
Publicado: (2021)

Perifollicular Xanthoma Occurring in Patients after Erlotinib Treatment
por: Kim, En Hyung, et al.
Publicado: (2022)

Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
por: Han, Ji Min, et al.
Publicado: (2023)

Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects
por: Han, Ji Min, et al.
Publicado: (2020)

Early monitoring for detection of antituberculous drug-induced hepatotoxicity
por: Lee, Chang Min, et al.
Publicado: (2016)

Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
por: Kim, Choong Hee, et al.
Publicado: (2022)

Associations of GNAS and RGS Gene Polymorphisms with the Risk of Ritodrine-Induced Adverse Events in Korean Women with Preterm Labor: A Cohort Study
por: Jang, Eun-Jeong, et al.
Publicado: (2022)

A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence
por: Song, Gonjin, et al.
Publicado: (2021)

Effects of Ephedrine-Containing Products on Weight Loss and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yoo, Hee-Jeong, et al.
Publicado: (2021)

Global Research Trends of Gender-Related Artificial Intelligence in Medicine Between 2001–2020: A Bibliometric Study
por: Yoon, Ha Young, et al.
Publicado: (2022)

Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity
por: Cho, Sungjoon, et al.
Publicado: (2023)

Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
por: Jeong, Jin Seob, et al.
Publicado: (2011)

Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and Their Serum Levels
por: Jeong, Ina, et al.
Publicado: (2015)

A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non–small cell lung cancer with EGFR mutation
por: Lee, Youngjoo, et al.
Publicado: (2022)

Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products
por: Patel, Dhavalkumar N., et al.
Publicado: (2015)

Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas
por: Cho, Yoon Young, et al.
Publicado: (2013)

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
por: Lim, Jae Yun, et al.
Publicado: (2015)

Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis
por: Choi, Hye Duck, et al.
Publicado: (2020)

Analysis of Gene Expression in 4,4′-Methylenedianiline-induced Acute Hepatotoxicity
por: Oh, Jung-Hwa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_tchhusdcrv1smbugkujph98mpg